Market cap
$5,289 Mln
Recently Viewed
Clear AllMarket cap
$5,289 Mln
Revenue (TTM)
$2,283 Mln
P/E Ratio
82.8
P/B Ratio
3.2
Div. Yield
0 %
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
$40 Mln
ROE
0 %
ROCE
-- %
Industry P/E
--
EV/EBITDA
31
Debt to Equity
0.5
Book Value
$51.5
EPS
$1.3
Face value
--
Shares outstanding
31,148,700
CFO
$962.24 Mln
EBITDA
$1,223.00 Mln
Net Profit
$589.70 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
LHC Group (LHCG)
| 5.0 | 5.9 | 5.0 | 23.8 | 10.7 | 22.7 | 23.2 |
|
BSE Sensex*
| -9.5 | 5.5 | -6.0 | -4.3 | 8.7 | 9.9 | 11.5 |
|
Company
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
2016
|
|---|---|---|---|---|---|---|---|
|
LHC Group (LHCG)
| 17.8 | -35.7 | 54.8 | 46.7 | 52.9 | 34.0 | 0.9 |
|
BSE Sensex
| 4.4 | 22.0 | 15.8 | 14.4 | 5.9 | 27.9 | 1.9 |
|
BSE Sensex
| 4.4 | 22.0 | 15.8 | 14.4 | 5.9 | 27.9 | 1.9 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
LHC Group (LHCG)
|
169.8 | 5,289.4 | 2,282.8 | 39.9 | 4.4 | 2.5 | 82.8 | 3.2 |
| 20.8 | 4,335.2 | 3,948.7 | -0.7 | 0.4 | -0.5 | -- | 24.2 | |
| 40.5 | 18,771.0 | 194,777.0 | -6,673.0 | -3.3 | -28.8 | -- | 1.0 | |
| 276.3 | 73,825.6 | 274,952.0 | 5,957.0 | 3.4 | 14.4 | 12.5 | 1.7 | |
| 2.4 | 1,149.0 | 1,924.3 | -85.6 | -4.4 | -26.3 | -- | 3.7 | |
| 346.6 | 69,758.1 | 199,125.0 | 5,662.0 | 4.1 | 13.3 | 12.5 | 1.6 | |
| 214.4 | 23,905.7 | 129,664.0 | 1,188.0 | 1.6 | 7 | 20.2 | 1.3 | |
| 0.0 | 0.0 | 10.8 | -31.2 | -259.9 | 1164.6 | -- | 8.9 | |
| 17.8 | 1,484.1 | 1,288.7 | 58.5 | 7.2 | 12.5 | 27.5 | 2.8 | |
| 354.1 | 278,574.8 | 447,567.0 | 12,056.0 | 4.2 | 12.9 | 23.2 | 3.0 |
LHC Group, Inc., a health care provider, specializes in the post-acute continuum of care primarily for Medicare beneficiaries in the United States. It operates through five segments: Home Health Services, Hospice Services, Home and Community-Based... Services, Facility-Based Services, and Healthcare Innovations (HCI). The Home Health Services segment offers skilled nursing, medically oriented social services and physical, occupational, and speech therapy. The Hospice Services segment provides pain and symptom management accompanied by palliative medication, emotional and spiritual support, inpatient and respite care, homemaker services, dietary counseling, family bereavement counseling, and social worker visits. Its Home and Community-Based Services segment offers range of services, such as assistance with grooming, medication reminders, meal preparation, assistance with feeding, light housekeeping, respite care, transportation, and errand. The Facility-Based Services segment treats patients with severe medical conditions who require a high-level of care and frequent monitoring by physicians and other clinical personnel. This segment serves patients suffering from respiratory failure, neuromuscular and cardiac disorders, non-healing wounds, renal disorders, cancer, head and neck injuries, and mental disorders, as well as treats patients diagnosed with musculoskeletal impairments; and operates nursing facilities, family health center, rural health clinic, and physician practice, as well as offers physical therapy services. The HCI segment provides strategic health management services to accountable care organizations. The company was founded in 1994 and is based in Lafayette, Louisiana. As of February 22, 2023, LHC Group, Inc. operates as a subsidiary of OptumHealth, Inc.. Read more
Co-Founder, CEO & Chairman
Mr. Keith G. Myers
Co-Founder, CEO & Chairman
Mr. Keith G. Myers
Headquarters
Lafayette, LA
Website
Our rating system has guided millions of investors in the past 20 years.
The share price of LHC Group (LHCG) is $169.81 (NASDAQ) as of 03-Mar-2023 09:30 EDT. LHC Group (LHCG) has given a return of 10.67% in the last 3 years.
The P/E ratio of LHC Group (LHCG) is 82.83 times as on 10-Mar-2023.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2022
|
125.72
|
3.14
|
|
2021
|
36.76
|
2.72
|
|
2020
|
59.26
|
4.33
|
|
2019
|
44.61
|
3.02
|
|
2018
|
41.35
|
2.00
|
The 52-week high and low of LHC Group (LHCG) are Rs -- and Rs -- as of 24-Apr-2026.
LHC Group (LHCG) has a market capitalisation of $ 5,289 Mln as on 10-Mar-2023. As per SEBI classification, it is a company.
Before investing in LHC Group (LHCG), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.